3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Neoplasms
41
Breast Neoplasms
40
Lung Neoplasms
25
Carcinoma, Non-Small-Cell Lung
20
Colorectal Neoplasms
19
Uterine Cervical Neoplasms
13
Prostatic Neoplasms
13
Head and Neck Neoplasms
11
Carcinoma, Hepatocellular
11
Pancreatic Neoplasms
10
Melanoma
10
Ovarian Neoplasms
9
Neoplastic Cells, Circulating
7
Myelodysplastic Syndromes
7
Glioma
7
Esophageal Neoplasms
7
Endometrial Neoplasms
7
Brain Neoplasms
7
Sarcoma
6
Multiple Myeloma
6
Gastrointestinal Neoplasms
6
Carcinoma, Renal Cell
6
Triple Negative Breast Neoplasms
5
Neoplasm Metastasis
5
Leukemia, Myeloid, Acute
5
Disease
5
Colonic Neoplasms
5
Uveal Melanoma
4
Skin Neoplasms
4
Neoplasm, Residual
4
Interventions
Echocardiography
6
Doxorubicin
3
Carvedilol
3
empagliflozin
2
Social Determinants of Health
2
Electrocardiography
2
Cyclophosphamide
2
pegfilgrastim
1
dapagliflozin
1
Watchful Waiting
1
Vincristine
1
Vascular Stiffness
1
Trastuzumab
1
Tablets
1
Standard of Care
1
Rosuvastatin Calcium
1
Rituximab
1
Resistance Training
1
Pulse Wave Analysis
1
Prednisolone
1
Palliative Care
1
Observation
1
Methods
1
Lenalidomide
1
Hematologic Tests
1
Fenofibrate
1
Exercise Test
1
Environmental Biomarkers
1
EGFR tyrosine kinase inhibitor 324674
1
Dexrazoxane
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Blood Specimen Collection
×
1 year
×
Clear all
NCT07041827
2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
217 enrolled